poisar

Stocks · News reference

Sanara MedTech Q2 EPS $(0.05) Misses $0.02 Estimate, Sales $28.137M Miss $28.950M Estimate

Aug 11, 2026, 8:24 PMBenzinga Newsdesk

Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.02 by 350 percent. This is a 78.26 percent increase over losses of $(0.23) per share from the

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

SMTI
Source
benzinga
Observed
Aug 11, 2026, 8:24 PM
Checked
Aug 11, 2026, 8:24 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 5, 2026, 7:41 PMHalper Sadeh Llc

    Halper Sadeh LLC is Investigating Whether FBRX, LXFR, SMTI, MKTX are Obtaining Fair Deals for their Shareholders

    Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether insiders are receiving substantial benefits unavailable to ordinary shareholders and whether transaction terms limit competing offers. The investigations cover Forte Biosciences' sale to argenx, Luxfer Holdings' sale to Wynnchurch Capital affiliates, Sanara MedTech's sale to MiMedx Group, and MarketAxess Holdings' sale to Intercontinental Exchange.

    Read original at globenewswire-inc
    FBRXLXFRSMTIMKTX
  2. Aug 4, 2026, 6:11 PMHalper Sadeh Llc

    Halper Sadeh LLC is Investigating Whether MKTX, SMTI, LNTH are Obtaining Fair Deals for their Shareholders

    Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers.

    Read original at globenewswire-inc
    MKTXSMTILNTH
  3. Jul 30, 2026, 3:51 PMBrodsky & Smith

    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)

    Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether the boards of MarketAxess Holdings, CBIZ, Sanara MedTech, and TriCo Bancshares breached fiduciary duties by failing to conduct fair processes and potentially underpaying shareholders. The firm is seeking shareholders to discuss potential class action lawsuits.

    Read original at globenewswire-inc
    MKTXCBZSMTITCBK